Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Net Margin (2016 - 2025)

Cytokinetics (CYTK) has disclosed Net Margin for 16 consecutive years, with 268.08% as the latest value for Q4 2025.

  • Quarterly Net Margin changed N/A to 268.08% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 438.97% through Dec 2025, changed N/A year-over-year, with the annual reading at 747.21% for FY2025, 226958.0% down from the prior year.
  • Net Margin for Q4 2025 was 268.08% at Cytokinetics, up from 9199.79% in the prior quarter.
  • The five-year high for Net Margin was 15.38% in Q2 2022, with the low at 57391.16% in Q2 2024.
  • Average Net Margin over 5 years is 10940.21%, with a median of 6851.66% recorded in 2022.
  • The sharpest move saw Net Margin crashed -4250143bps in 2024, then skyrocketed 5720756bps in 2025.
  • Over 5 years, Net Margin stood at 64.69% in 2021, then crashed by -10492bps to 6851.66% in 2022, then dropped by -17bps to 8049.16% in 2023, then plummeted by -302bps to 32338.88% in 2024, then soared by 99bps to 268.08% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 268.08%, 9199.79%, and 183.6% for Q4 2025, Q3 2025, and Q2 2025 respectively.